Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMBALAL SARABHAI   MYLAN
EQUITY SHARE DATA
    AMBALAL SARABHAI
Mar-23
MYLAN
Dec-18
AMBALAL SARABHAI/
MYLAN
5-Yr Chart
Click to enlarge
High Rs393,978-   
Low Rs202,190-   
Sales per share (Unadj.) Rs22.21,830.6-  
Earnings per share (Unadj.) Rs1.449.7-  
Cash flow per share (Unadj.) Rs1.8392.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.11,980.4-  
Shares outstanding (eoy) m76.63514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 79.3%   
Avg P/E ratio x20.562.0 33.0%  
P/CF ratio (eoy) x16.47.9 208.9%  
Price / Book Value ratio x1.71.6 111.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,2741,586,770 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2520-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m1,703941,863 0.2%  
Other income Rs m1250-   
Total revenues Rs m1,828941,863 0.2%   
Gross profit Rs m78243,719 0.0%  
Depreciation Rs m28176,354 0.0%   
Interest Rs m2745,300 0.1%   
Profit before tax Rs m14822,065 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m37-3,510 -1.1%   
Profit after tax Rs m11125,575 0.4%  
Gross profit margin %4.625.9 17.7%  
Effective tax rate %25.1-15.9 -157.9%   
Net profit margin %6.52.7 240.1%  
BALANCE SHEET DATA
Current assets Rs m1,166525,936 0.2%   
Current liabilities Rs m952383,465 0.2%   
Net working cap to sales %12.615.1 83.3%  
Current ratio x1.21.4 89.4%  
Inventory Days Days8684 103.3%  
Debtors Days Days58293 624.1%  
Net fixed assets Rs m1,291182,706 0.7%   
Share capital Rs m766501 152.8%   
"Free" reserves Rs m5430-   
Net worth Rs m1,3091,018,924 0.1%   
Long term debt Rs m1811,099,746 0.0%   
Total assets Rs m2,4572,733,150 0.1%  
Interest coverage x6.51.5 435.2%   
Debt to equity ratio x0.11.1 12.8%  
Sales to assets ratio x0.70.3 201.1%   
Return on assets %5.62.6 216.7%  
Return on equity %8.52.5 337.8%  
Return on capital %11.83.2 370.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m57195,719 0.0%  
From Investments Rs m-168-101,165 0.2%  
From Financial Activity Rs m91-91,177 -0.1%  
Net Cashflow Rs m-201,621 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare AMBALAL SARABHAI With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AMBALAL SARABHAI With: VENUS REMEDIES  SHILPA MEDICARE  NECTAR LIFESCIENCE  SUVEN LIFE SCIENCES  ALPA LAB  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.